ArticleCureus2025
Lip Verrucous Tumor in a Male With Chronic Graft-Versus-Host Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Animal models of chronic graft-versus-host disease with oral involvement: A review.European journal of oral sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Verruciform xanthoma (VX) is a rare benign tumor that usually occurs in the oral area or the urogenital region. Although VX sometimes arises in the oral space, VX on the lip is rare. The ratio of oral VX in chronic graft-versus-host disease (cGVHD) patients might be higher than that of the general population, and the frequency of lip cases may also be higher in cGVHD patients. In some cases, VX mimics malignant tumors such as verrucous carcinoma or squamous cell carcinoma. It is important to distinguish VX from malignant tumors to prevent excessive excision. Our case is a VX on the lower lip of a cGVHD patient. It was diagnosed by skin biopsy and treated by total excision. When we find a verrucous or papillary tumor, especially in a cGVHD patient, VX should be a candidate for diagnosis, as well as verruca vulgaris or verrucous carcinoma, to prevent unnecessary extensive excision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.